Best Buy Co., Inc. (NYSE:BBY) shares moved up 1.87% in last trading session and ended the day at $35.48. BBY Gross Margin is 22.90% and its has a return on assets of 10.40%. Best Buy Co., Inc. (NYSE:BBY) quarterly performance is 8.58%.
Best Buy Co (NYSE:BBY) has earned a “BB-” credit rating from Morningstar. The firm’s “BB-” rating suggests that the company is an above-average default risk. They also gave their stock a three star rating.
Nokia Corporation (ADR) (NYSE:NOK) ended the last trading day at $7.07. Company weekly volatility is calculated as 1.62% and price to cash ratio as 3.42. Nokia Corporation (ADR) (NYSE:NOK) showed a weekly performance of 0.43%.
Nokia Corporation (ADR) (NYSE:NOK) announced that it has decided to exercise its option to redeem its EUR 750 million convertible bonds due in 2017 (the “Convertible Bonds”) on November 26, 2015 at their principal amount outstanding plus accrued interest, and has today sent a redemption notice to all holders of the Convertible Bonds.
On 15 October, IAMGOLD Corp. (NYSE:IAG) shares moved up 0.96% and was closed at $2.10. IAG EPS growth in last 5 year was -42.10%. IAMGOLD Corp. (NYSE:IAG) year to date (YTD) performance is -22.22%.
IAMGOLD Corporation (NYSE:IAG) will release its third quarter 2015 financial results after market hours on Tuesday, November 3rd, 2015.
Noble Corp plc (NYSE:NE) shares moved up 0.41% in last trading session and ended the day at $12.32. NE Gross Margin is 54.10% and its has a return on assets of -1.10%. Noble Corp plc (NYSE:NE) quarterly performance is -5.10%.
Noble Corporation plc (NYSE:NE) announced it plans to report financial results for the third quarter 2015 on Wednesday, October 28, 2015, after the close of trading on the New York Stock Exchange.
Flex Pharma, Inc. (NASDAQ:FLKS) caters to the Healthcare space. Its weekly performance is -14.81%. On the last day of trading company shares ended up at $10.93. Flex Pharma, Inc. (NASDAQ:FLKS) distance from 50-day simple moving average (SMA50) is -16.23%.
Flex Pharma, Inc. (NASDAQ:FLKS), announced that Chief Medical Officer, Dr. Tom Wessel, will lead a panel of thought leaders including National Academy of Sciences member Dr. Bruce Bean, Professor of Neurobiology at Harvard Medical School, regarding chemical neuro stimulation as a new therapeutic modality to treat and prevent muscle cramps and spasms, at the Neuro Advance Boston Conference on October 14, 2015, held at Harvard Medical School.
Leave a Reply